Skip to content

Clinical trials

Withdrawn Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Withdrawn Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20131
20151
20161
20182
20191
20201
20213
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital2
Eidos Therapeutics, a BridgeBio company2
Alfred Chung, MD1
GlaxoSmithKline1
Mayo Clinic1
North Florida Foundation for Research and Education1
Sherif S. Farag1
Sorrento Therapeutics, Inc.1
Stanford University1
Tufts Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis15
Alzheimer Disease3
Amyloid Neuropathies, Familial3
Amyloidosis, Familial2
Cardiomyopathies2
Immunoglobulin Light-chain Amyloidosis2
Polyneuropathies2
Mucositis1
Multiple Myeloma1
Paraproteinemias1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.